The deal size was increased to $250M in common stock from $220M in common stock. Jefferies, Leerink, Morgan Stanley and Cantor Fitzgerald acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRON:
- Disc Medicine’s Strategic Positioning and Growth Potential Highlighted by Analyst’s Buy Rating
- Disc Medicine Updates Hematology Portfolio and Strategic Priorities
- Disc Medicine commences underwritten offering of $220M of shares
- Disc Medicine announces progress and strategic priorities for 2025 and 2026
- Midday Fly By: Apple new F1 broadcast partner, CSX reports Q3 beat